243 related articles for article (PubMed ID: 24053229)
21. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
Dhakhwa R; Kafle N
JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
[TBL] [Abstract][Full Text] [Related]
22. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
23. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
24. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
25. Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.
Okano K; Oshima M; Yachida S; Kushida Y; Kato K; Kamada H; Wato M; Nishihira T; Fukuda Y; Maeba T; Inoue H; Masaki T; Suzuki Y
J Surg Oncol; 2014 Aug; 110(2):156-62. PubMed ID: 24619853
[TBL] [Abstract][Full Text] [Related]
26. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
[TBL] [Abstract][Full Text] [Related]
27. Morphology, TNM staging and survival with Pancreatico-duodenectomy specimens received at Shaukat Khanum Memorial Cancer Hospital and Research Centre, Pakistan.
Qureshi A; Hassan U; Azam M
Asian Pac J Cancer Prev; 2011; 12(4):953-6. PubMed ID: 21790232
[TBL] [Abstract][Full Text] [Related]
28. Longterm survival after pancreaticoduodenectomy for periampullary adenocarcinomas.
Chen SC; Shyr YM; Wang SE
HPB (Oxford); 2013 Dec; 15(12):951-7. PubMed ID: 23472708
[TBL] [Abstract][Full Text] [Related]
29. The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.
Ang DC; Shia J; Tang LH; Katabi N; Klimstra DS
Am J Surg Pathol; 2014 Oct; 38(10):1371-9. PubMed ID: 24832159
[TBL] [Abstract][Full Text] [Related]
30. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.
Chandrasegaram MD; Gill AJ; Samra J; Price T; Chen J; Fawcett J; Merrett ND
World J Gastrointest Oncol; 2017 Oct; 9(10):407-415. PubMed ID: 29085567
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.
da Silveira Santos JPL; Machado CJ; Junior EP; Rodrigues JBSR; Vidigal PT; Resende V
J Gastrointest Surg; 2018 Jul; 22(7):1171-1178. PubMed ID: 29736668
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.
Chong Y; Thakur N; Paik KY; Lee EJ; Kang CS
BMC Cancer; 2020 Mar; 20(1):216. PubMed ID: 32171280
[TBL] [Abstract][Full Text] [Related]
33. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
Byrling J; Ghazi S; Andersson B
BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
[TBL] [Abstract][Full Text] [Related]
34. Results of pancreaticoduodenectomy in patients with periampullary adenocarcinoma: perineural growth more important prognostic factor than tumor localization.
van Roest MH; Gouw AS; Peeters PM; Porte RJ; Slooff MJ; Fidler V; de Jong KP
Ann Surg; 2008 Jul; 248(1):97-103. PubMed ID: 18580212
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing survival after resection for periampullary neoplasms.
Bouvet M; Gamagami RA; Gilpin EA; Romeo O; Sasson A; Easter DW; Moossa AR
Am J Surg; 2000 Jul; 180(1):13-7. PubMed ID: 11036132
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression of CDX2, CK7, HER2 and HER4 in periampullary adenocarcinoma : implications for clinicopathology and patient outcomes.
Uğraş N; Yerci Ö; Özgün G; Deligönül A; Dündar HZ; Sarkut P; Kanat Ö
Acta Gastroenterol Belg; 2017; 80(1):31-37. PubMed ID: 29364095
[TBL] [Abstract][Full Text] [Related]
38. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
39. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
40. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases.
Seidel G; Zahurak M; Iacobuzio-Donahue C; Sohn TA; Adsay NV; Yeo CJ; Lillemoe KD; Cameron JL; Hruban RH; Wilentz RE
Am J Surg Pathol; 2002 Jan; 26(1):56-63. PubMed ID: 11756769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]